Exec Director, Asset Team Leader

Role Summary

Exec Director, Asset Team Leader will lead teams covering multiple HIV-related assets across early- to late-phase and marketed products. The role involves developing and executing cohesive asset strategies, enabling cross-functional collaboration, and guiding portfolio governance and decision-making to deliver program milestones. This position requires strong leadership to align global teams, manage complex programs, and communicate effectively with senior leadership.

• Strategic Asset Leadership:
  Lead asset teams in developing and executing cohesive asset and program strategies, aligning with broader organizational goals through resource assessment, timeline management, and risk mitigation.
• Cross-functional Collaboration:
  
  Enable strong collaboration around a shared asset vision, ensuring transparent flow of asset-related information and decisions across teams and partners.
• Accountability for Delivery:
  Ensure timely achievement of key asset milestones; monitor progress against the Target Product Profile (TPP), Asset Plan, and Lifecycle Plan (LCP) with respect to timelines and budgets.
• Integrated Strategy Development:
  Develop and present global asset strategies spanning product development, manufacturing, commercialization and lifecycle management, adapting plans as clinical, regulatory, or commercial landscapes evolve.
• Governance and Decision Facilitation:
  Facilitate decisions with cross-functional insights, drive scenario planning and risk analysis, and communicate with senior leadership and governance bodies; set Go/No Go decision points and present data to Portfolio Committee.
• Team Leadership:
  Align cross-functional teams around a unified asset vision, foster clear roles and accountability, and cultivate a high-performing, inclusive and collaborative team environment.
• Stakeholder Engagement:
  Build and maintain strong relationships with internal and external partners to support program success and innovation.
• Operational Excellence:
  Ensure excellence in operationalization of integrated asset strategy and stakeholder activities to deliver program milestones.
• Scientific and Medical Advocacy:
  Articulate and champion asset strategies, scientific rationale, and clinical objectives to diverse audiences.
• Portfolio and Therapeutic Area Strategy:
  Advise on disease area strategies for discovery, innovation, development, and lifecycle planning in collaboration with Therapeutic Area Leaders and Business Development.

• Advanced scientific, medical, or commercial background with expertise in drug development and relevant therapeutic areas; proven ability to make complex decisions with an enterprise perspective.
• Demonstrated cross-functional leadership across global initiatives, effectively managing projects and executing strategic plans.
• Proven ability to lead multidisciplinary teams and integrate discovery, development, regulatory, and commercial considerations across all asset lifecycle phases.
• Able to lead, influence, and deliver significant impact even in the absence of direct authority.
• Exceptional communication, organizational, and decision-making skills, able to resolve complex issues and influence senior leaders.
• Track record of high-level performance and strategic value delivery within global pharmaceutical or biotech organizations.
• Comprehensive understanding of the drug development process, including full asset lifecycle management and end-to-end brand exposure.

• Bachelor’s degree in a scientific or business discipline required; advanced degrees such as PhD, MD, or MBA highly preferred. For some GATL roles, an MD or PhD may be prioritized.
• 12+ years’ biopharmaceutical industry experience preferred, with at least 8 years in relevant roles within biotech/pharmaceutical organizations.
• Comprehensive knowledge of the overall drug development process, with experience in commercial launches and program/asset strategy teams strongly desired.
• Minimum Experience requirements for Executive Director Level: 16+ with BS; 14+ MS or PhD; 8+ years with MD.